Trials / Completed
CompletedNCT00177099
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
Neurotrophic Effects of Immunophilin Ligands on Human Hair Follicles Grafted Onto Service Combined Immunodeficient (SCID) Mice
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (planned)
- Sponsor
- Hordinsky, Maria K., MD · Individual
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if immunophilin ligands may have the potential to reverse hair loss.
Detailed description
Preliminary experiments in C57BL/6J mice showed that immunophilin ligand FK506 and its non-immunosuppressive analogs, GP11046 and GP11511 were capable of promoting telogen to anagen transition. Since GP11046 and GP11511 possess the neurotrophic properties of FK506 without its immunosuppressant capability, the neural action of these immunophilin ligands may play an important role in the hair cycle. This finding has significant clinical implications in that immunophilin ligands may have the potential to reverse alopecia. To further investigate this possibility we propose to explore the response of transplanted miniaturized scalp hair follicles to topically applied immunophilin ligands.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FK506, GP11046, GP11511 |
Timeline
- Start date
- 2003-07-01
- Completion
- 2004-09-01
- First posted
- 2005-09-15
- Last updated
- 2006-11-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00177099. Inclusion in this directory is not an endorsement.